Notice: This company has been marked as potentially delisted and may not be actively trading. Cardiff Oncology (TROV) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsHeadlinesTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Cardiff Oncology Reports Positive Q3 2024 Results and Clinical ProgressNovember 9, 2024 | markets.businessinsider.comCardiff Oncology Reports Third Quarter 2024 Results and Provides Business UpdateNovember 8, 2024 | markets.businessinsider.comCardiff Oncology publishes onvansertib combination data in journalNovember 1, 2024 | markets.businessinsider.comCardiff Oncology: Paramount Data Imminent In Huge First-Line mCRC MarketOctober 4, 2024 | seekingalpha.comCraig-Hallum Sticks to Its Buy Rating for Cardiff Oncology (CRDF)September 13, 2024 | markets.businessinsider.comCardiff: Second Half Of 2024 mCRC Data Is Major Inflection PointAugust 12, 2024 | seekingalpha.comCardiff Oncology, Inc. (NASDAQ:CRDF) Q2 2024 Earnings Call TranscriptAugust 12, 2024 | msn.comCRDF Stock Earnings: Cardiff Oncology Misses EPS, Beats Revenue for Q2 2024August 9, 2024 | markets.businessinsider.comCardiff Oncology Reports Second Quarter 2024 Results and Provides Business UpdateAugust 9, 2024 | markets.businessinsider.comCardiff Oncology's Onvansertib: A Speculative Buy With Promising DataMay 22, 2024 | seekingalpha.comBuy Rating Affirmed on Cardiff Oncology as Phase 2 Trial Shows Promise for Accelerated ApprovalMay 7, 2024 | markets.businessinsider.comCardiff Oncology Stock (NASDAQ:CRDF) Dividends: History, Yield and DatesFebruary 23, 2024 | benzinga.comCardiff Oncology’s Onvansertib Shows Promise: An Analysis of the Buy Rating RecommendationSeptember 29, 2023 | markets.businessinsider.comStocks to Watch: MillerKnoll, Cardiff Oncology, Morphic HoldingsSeptember 26, 2023 | marketwatch.comCardiff Oncology Shares Up 26% After Potential Cancer Treatment AdvancesAugust 8, 2023 | marketwatch.comH.C. Wainwright Sticks to Their Buy Rating for Cardiff Oncology (CRDF)August 8, 2023 | markets.businessinsider.comCardiff Oncology (NASDAQ: CRDF)May 27, 2023 | fool.comCardiff OncologyJanuary 13, 2023 | forbes.comCardiff Oncology: Staying The CourseDecember 14, 2022 | seekingalpha.comClear Channel Outdoor And 2 Other Penny Stocks Insiders Are Aggressively BuyingOctober 16, 2022 | markets.businessinsider.comCardiff Oncology, Inc. (CRDF)September 29, 2022 | finance.yahoo.comCRDF Cardiff Oncology, Inc.September 24, 2022 | seekingalpha.comLooking Into Cardiff Oncology's Return On Capital EmployedAugust 25, 2022 | msn.comCardiff Oncology: Down But Not OutAugust 22, 2022 | seekingalpha.comCardiff Oncology (CRDF) Expected to Beat Earnings Estimates: Can the Stock Move Higher?July 28, 2022 | finance.yahoo.com5 Oncology Stocks Wall Street Predicts Will Rally 135% or MoreMay 31, 2022 | stocknews.comCardiff Oncology to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLCMarch 22, 2022 | prnewswire.comCardiff Oncology Reports Second Quarter 2021 Results and Provides Business UpdatesAugust 5, 2021 | prnewswire.com Get Cardiff Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter. Email Address Breaking News: Tesla headed to $500… (Ad)That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. TROV Media Mentions By Week TROV Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TROV News Sentiment▼0.000.50▲Average Medical News Sentiment TROV News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TROV Articles This Week▼00▲TROV Articles Average Week Get Cardiff Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for TROV and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies VXRT News Today INMB News Today SCLX News Today IPSC News Today CLLS News Today QNCX News Today CABA News Today HLVX News Today GNTA News Today IVVD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TROV) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cardiff Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cardiff Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TROV Stock Alerts